← Leaderboards
Priscilla Cheung
Harvard Medical School
$85,846
Attributed
$85,846
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $38.1K · FY2019–21$50K$37.5K$25K$12.5K$0
'19
'20
'21
Funding mix
By agency
NIH$85,846 · 1
By mechanism
F31$85,846 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Gerhard Wagner$49,510,293
- Zachary T. Schafer$2,217,107
- Norbert Perrimon$95,273,017
- Dmitri N Ivanov$5,698,728
- Arlene H Sharpe$68,359,602
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectApoptosisBreast Cancer ProgressionCancer Cell LineCancer InitiationCancer PatientCandidate Disease GeneCell LineCell PhysiologyCell ProliferationChimeric ProteinsGenesGeneticGenetic TranscriptionHaploid CellsHaploidyHomeostasisInsightIn VitroMalignant Breast NeoplasmMalignant NeoplasmsMediatingMouse Model5&Apos
Grant awards (3)
Role of DHX29 in the regulation of Hippo pathway effectors YAP/TAZ in cancer$14,475
F31 · FY2021 · CA · contact PI
Role of DHX29 in the regulation of Hippo pathway effectors YAP/TAZ in cancer$33,283
F31 · FY2020 · CA · contact PI
Role of DHX29 in the regulation of Hippo pathway effectors YAP/TAZ in cancer$38,088
F31 · FY2019 · CA · contact PI